NCT01290029 Study to Evaluate Cinacalcet in Children With Chronic Kidney Disease Status COMPLETED Phase PHASE1
NCT01288339 Study Assessing Potential Predictive Tumor Markers in Metastatic Colorectal Cancer Status COMPLETED Phase PHASE2
NCT01285310 Study of Apremilast to Evaluate the Safety and Effectiveness for Patients With Rheumatoid Arthritis Status TERMINATED Phase PHASE2
NCT01270347 Trial of Aeroquin Versus Tobramycin Inhalation Solution (TIS) in Cystic Fibrosis (CF) Patients Status COMPLETED Phase PHASE3
NCT01264328 Study of the Combination of Panitumumab With Paclitaxel as First-line Treatment of Subjects With Head and Neck Cancer Status COMPLETED Phase PHASE2
NCT01257737 To Evaluate the Safety of Long-term Use of HPN-100 in the Management of Urea Cycle Disorders (UCDs) Status COMPLETED Phase PHASE4
NCT01253681 Study of AMG 386 in Combination With Paclitaxel and Carboplatin in Subjects With Ovarian Cancer Status COMPLETED Phase PHASE1
NCT01250405 Acute Effects of Cinacalcet on Arterial Stiffness and Ventricular Function in Hemodialysis Patients Status COMPLETED Phase PHASE4
NCT01242917 A Study to Evaluate the Safety and Efficacy of CCX354-C in Subjects With Rheumatoid Arthritis Partially Responsive to Methotrexate Therapy Status COMPLETED Phase PHASE2
NCT01235442 Evaluate Efficacy, and Safety of Topical Therapy and Etanercept in Subjects With Moderate to Severe Plaque Psoriasis Status COMPLETED Phase PHASE3
NCT01235416 A Phase 1b, Open-label, Dose-finding Study of AMG 706 in Combination With Gemcitabine and Erlotinib to Treat Subjects With Solid Tumors Status COMPLETED Phase PHASE1
NCT01234324 ECX + Panitumumab vs. ECX Alone in Locally Advanced Gastric Cancer or Cancer of the Gastroesophageal Junction Status COMPLETED Phase PHASE2
NCT01233687 AMG 102 and Erlotinib for Advanced Non-Small Cell Lung Cancer Status COMPLETED Phase PHASE1/PHASE2
NCT01232283 Study to Evaluate Safety and Effectiveness of Oral Apremilast (CC-10004) in Patients With Moderate to Severe Plaque Psoriasis. Status COMPLETED Phase PHASE3
NCT01226719 FOLFOXIRI Plus Panitumumab Patients With Metastatic KRAS Wild-Type Colorectal Cancer With Liver Metastases Only Status COMPLETED Phase PHASE2